Clinical Trials · NCT06461039

A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant

CompletedPhase 1Amycretin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
43
Start date
Jun 2024
Locations
1 site, Canada
Primary endpoint
The area under the ethinylestradiol plasma concentration time curve at steady state
View Amycretin compound reference